Daniela Annenelie Bota

University of California-Irvine

NIH Rank #11880
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.2M
Fiscal year 2024
Grants Awarded
7
Active NIH grants
National Rank
#11,880
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.2M across 7 grants · National rank #11880.

Top grants by award amount

Daniela Annenelie Bota's NIH grant portfolio, ranked by award amount.

  • 5R01CA263806-04R01
    Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
    $574.8K
    award amount
  • 5R01NS109423-05R01
    Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
    $399.3K
    award amount
  • 3R01CA263806-04S2R01
    Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
    $95.5K
    award amount
  • 3R01CA263806-04S1R01
    Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
    $82.5K
    award amount
  • 3R01CA263806-03S1R01
    Supplement to Promote Diversity: Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
    $33.1K
    award amount
  • 3R01CA263806-03S2R01
    Supplement to Promote Diversity:Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
    $18.3K
    award amount
  • 3R01NS109423-05S1R01
    Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
    $9.1K
    award amount

Affiliation

Institutions that have administered grants for Daniela Annenelie Bota.

Affiliated with University of California-Irvine (CA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of California-Irvine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding